Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies and New Accounting Standards (Tables)

v3.26.1
Summary of Significant Accounting Policies and New Accounting Standards (Tables)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies and New Accounting Standards [Abstract]  
Schedule of Measured at Fair Value on a Recurring Basis

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

          Fair value measurements at reporting date using:  
    Fair value     Quoted prices
in active
markets for
identical
liabilities
(Level 1)
    Significant
other
observable
inputs
(Level 2)
    Significant
unobservable
inputs
(Level 3)
 
Assets:                        
Cash equivalents, March 31, 2026   $ 50,400,377     $ 50,400,377     $            -     $ -  
Cash equivalents, December 31, 2025   $ 55,158,939     $ 55,158,939     $ -     $ -  
                                 
Liabilities:                                
Public warrant liabilities, March 31, 2026   $ -     $ -     $ -     $ -  
Representative warrant liabilities, March 31, 2026   $ 52,966     $ -     $ -     $ 52,966  
                                 
Liabilities:                                
Public warrant liabilities, December 31, 2025   $ 3,842,857     $ 3,842,857     $ -     $ -  
Representative warrant liabilities, December 31, 2025   $ 46,871     $ -     $ -     $ 46,871  
Schedule of Reconciliation of the Level 3 Representative Warrant Liabilities

The following table presents a reconciliation of the Level 3 Representative Warrant liabilities:

 

    Three Months Ended
March 31,
 
    2026     2025  
Representative warrant liabilities, January 1   $ 46,871     $ 9,932  
Issuances     -       -  
Exercises     -       -  
Change in fair value     6,095       (4,708 )
Representative warrant liabilities, March 31   $ 52,966     $ 5,224  

The following table presents a reconciliation of the Level 3 Derivative Warrant liabilities:

 

    Three Months Ended
March 31,
 
    2026     2025  
Derivative warrant liabilities, January 1   $ 3,842,857     $ -  
Issuances     -       -  
Exercises     -       -  
Change in fair value     (1,548,227 )     -  
Reclassification to equity     2,294,631          
Derivative warrant liabilities, March 31   $ -     $ -  
Schedule of Net Loss Per Share The following outstanding shares of common stock issuable upon exercise of stock options and warrants were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:
    Three Months Ended
March 31,
 
    2026     2025  
Stock options     1,685,843       164,846  
Warrants     13,090,120       3,293,692  
Schedule of Relevant Translation Rates

The relevant translation rates are as follows:

 

    As of
March 31,
    As of
December 31,
 
    2026     2025  
Closing rate, British Pound (GBP) to $USD at period end     N/A       N/A  
Average rate, GBP to $USD for the period ended     N/A       N/A  
Closing rate, Euro (EUR) to $USD at period end     N/A       N/A  
Average rate, EUR to $USD for the period ended     N/A       N/A  
Closing rate, Australian Dollar (AUD) to $USD at period end     0.7022       0.6669  

Average rate, AUD to $USD for the period of subsidiary inception to period end

    0.6898       0.6450